Ryan Savitz

EVP, CFO & CBO

Ryan Savitz (EVP, CFO & CBO) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Dianthus Therapeutics, Inc. (DNTH). The largest single filing was $9.4M of DNTH (113,567 sh across 7 lots, as filed), executed Mar 31.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$14.2M

shares × price, as filed

Last traded

Jul 9

Filed Jul 13

Median ADV $122.5M across their filed names

Open performance→

Volume by month

Buys $0 Sells $14.9M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

DNTH

Dianthus Therapeutics, Inc. DNTH · 0 buys · 5 sells 5 filings

Recent filings

DNTHSALE Dianthus Therapeutics, Inc. View filing → $3.2M
31,249 sh across 3 lots
Exec Jul 9
Filed Jul 13 · 5:00 PM ET DNTHSALE Dianthus Therapeutics, Inc. View filing → $739K
8,224 sh × $89.84
Exec Apr 9
Filed Apr 10 · 5:30 PM ET DNTHSALE Dianthus Therapeutics, Inc. View filing → $9.4M
113,567 sh across 7 lots
Exec Mar 31
Filed Apr 1 · 5:30 PM ET DNTHSALE Dianthus Therapeutics, Inc. View filing → $904K
20,000 sh × $45.18
Exec Dec 4 2025
Filed Dec 5 2025 · 5:30 PM ET DNTHSALE Dianthus Therapeutics, Inc. View filing → $700K
20,000 sh × $35.00
Exec Sep 9 2025
Filed Sep 11 2025 · 5:30 PM ET